company background image
A036480 logo

Daesung Microbiological Labs KOSDAQ:A036480 Stock Report

Last Price

₩10.56k

Market Cap

₩40.1b

7D

2.5%

1Y

6.5%

Updated

24 Mar, 2024

Data

Company Financials

Daesung Microbiological Labs. Co., Ltd.

KOSDAQ:A036480 Stock Report

Market Cap: ₩40.1b

A036480 Stock Overview

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea.

A036480 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Daesung Microbiological Labs. Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Daesung Microbiological Labs
Historical stock prices
Current Share Price₩10,560.00
52 Week High₩19,450.00
52 Week Low₩9,680.00
Beta0.85
1 Month Change0.96%
3 Month Change-8.73%
1 Year Change6.45%
3 Year Change-41.66%
5 Year Change-44.13%
Change since IPO-42.61%

Recent News & Updates

Recent updates

Is Daesung Microbiological Labs (KOSDAQ:036480) Using Too Much Debt?

May 08
Is Daesung Microbiological Labs (KOSDAQ:036480) Using Too Much Debt?

Is The Market Rewarding Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

Mar 15
Is The Market Rewarding Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

We're Not Counting On Daesung Microbiological Labs (KOSDAQ:036480) To Sustain Its Statutory Profitability

Feb 17
We're Not Counting On Daesung Microbiological Labs (KOSDAQ:036480) To Sustain Its Statutory Profitability

Is Daesung Microbiological Labs (KOSDAQ:036480) A Risky Investment?

Jan 21
Is Daesung Microbiological Labs (KOSDAQ:036480) A Risky Investment?

Update: Daesung Microbiological Labs (KOSDAQ:036480) Stock Gained 83% In The Last Five Years

Dec 31
Update: Daesung Microbiological Labs (KOSDAQ:036480) Stock Gained 83% In The Last Five Years

Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

Dec 10
Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

Here's Why We Don't Think Daesung Microbiological Labs's (KOSDAQ:036480) Statutory Earnings Reflect Its Underlying Earnings Potential

Nov 19
Here's Why We Don't Think Daesung Microbiological Labs's (KOSDAQ:036480) Statutory Earnings Reflect Its Underlying Earnings Potential

Shareholder Returns

A036480KR BiotechsKR Market
7D2.5%4.0%3.2%
1Y6.5%22.1%13.4%

Return vs Industry: A036480 underperformed the KR Biotechs industry which returned 22.1% over the past year.

Return vs Market: A036480 underperformed the KR Market which returned 13.4% over the past year.

Price Volatility

Is A036480's price volatile compared to industry and market?
A036480 volatility
A036480 Average Weekly Movement4.0%
Biotechs Industry Average Movement8.0%
Market Average Movement5.2%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A036480 has not had significant price volatility in the past 3 months.

Volatility Over Time: A036480's weekly volatility has decreased from 10% to 4% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1966n/aHang-Won Chohttps://www.dsmbio.co.kr

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products.

Daesung Microbiological Labs. Co., Ltd. Fundamentals Summary

How do Daesung Microbiological Labs's earnings and revenue compare to its market cap?
A036480 fundamental statistics
Market cap₩40.13b
Earnings (TTM)-₩679.68m
Revenue (TTM)₩25.56b

1.6x

P/S Ratio

-59.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A036480 income statement (TTM)
Revenue₩25.56b
Cost of Revenue₩20.86b
Gross Profit₩4.70b
Other Expenses₩5.38b
Earnings-₩679.68m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-178.86
Gross Margin18.41%
Net Profit Margin-2.66%
Debt/Equity Ratio63.8%

How did A036480 perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.